Ascorbic acid inhibits human insulin aggregation and protects against amyloid induced cytotoxicity

Interplay of multiple interaction forces: Binding of tyrosine kinase inhibitor nintedanib with human serum albumin

Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches

Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach

Investigating the site selective binding of busulfan to human serum albumin: Biophysical and molecular docking approaches

Fluorescence spectroscopic and molecular docking studies of the binding interaction between the new anaplastic lymphoma kinase inhibitor crizotinib and bovine serum albumin